IPP Bureau
.jpg "Promising prospects for Indian pharma: CLSA")
Promising prospects for Indian pharma: CLSA
By IPP Bureau - September 17, 2021
CLSA, a capital market and investment group organised an Investors’ Forum where five Indian pharma companies participated. Excerpts from the report
Machine Learning to understand and prevent disease
By IPP Bureau - September 17, 2021
Barbara Engelhardt moves her computational and statistics lab to Gladstone
Novavax to participate in Oxford university’s study on combining Covid-19 vaccines
By IPP Bureau - September 17, 2021
Study to explore heterologous regimen of COVID-19 vaccines from different manufacturers in adolescents 12-16 years of age
Argenta acquires Klifovet to expand global footprint in animal health
By IPP Bureau - September 17, 2021
Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups
Unum designs vaccine verification tool to track Covid-19 vaccination status
By IPP Bureau - September 17, 2021
It will also manage test result documentation for employees who are not vaccinated, sending weekly reminders and employer notification
Sakra World Hospital opens fertility centre
By IPP Bureau - September 17, 2021
It comes with a prime focus on infection control and patient flow as the primary infrastructure design aspects - the need of the hour and must-have during a pandemic.
DRDO places orders for oxygen generators with 10 companies
By IPP Bureau - September 16, 2021
Godrej and Boyce and Isgec Engineering have confirmed receiving the orders
DGCI gives a go-ahead for Phase III Sputnik Light trials
By IPP Bureau - September 16, 2021
The Lancet study said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against Covid-19, significantly higher than most two-shot vaccines
Allianz Partners expands its Digital Health Assistant to India
By IPP Bureau - September 16, 2021
Initially launched in Europe, this new service gives customers access to a range of digital health services and medical professionals and is part of its Digital Access to Care Initiative
Maharashtra to publicise health tips on social media
By IPP Bureau - September 16, 2021
Between 30-40 per cent of Covid-19 patients are either obese or diabetic
U.S. FDA approves Thermo Fisher Scientific’s Oncomine Dx target test
By IPP Bureau - September 16, 2021
It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
Lupin to settle litigations over diabetes drug
By IPP Bureau - September 16, 2021
The board has approved the settlement of US $ 248 million towards Direct Purchaser group and Retailer Opt-Out group subject to court approval
Roche set to acquire long-term partner TIB Molbiol
By IPP Bureau - September 16, 2021
The deal is expected to close in the fourth quarter of 2021 and will enable Roche to further expand the portfolio. TIB Molbiol excels in ultra-rapid assay development of emerging infectious diseases
Lancet study confirms Johnson & Johnson Ebola vaccine safe
By IPP Bureau - September 16, 2021
Data show the vaccine regimen induced neutralising antibody responses in nearly all participating adults and children 21 days after the second dose. Adults receiving booster shots two years after the initial vaccination regimen showed strong immune responses
NCLT approves amalgamation of Lincoln Parenteral with Lincoln Pharma
By IPP Bureau - September 16, 2021
The amalgamation is expected to bring in a lot of synergies in terms of operational efficiency and productivity for the combined entity
